% alzhub.org library filter % Source: https://alzhub.org/research?author=Porsteinsson+AP&score_min=67 % 7 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{porsteinsson2014-24549548, author = {Porsteinsson, A. P. and Drye, L. T. and Pollock, B. G. and Devanand, D. P. and Frangakis, C. and Ismail, Z. and Marano, C. and Meinert, C. L. and others}, title = {{Effect of citalopram on agitation in Alzheimer disease: the CitAD randomized clinical trial}}, journal = {JAMA}, year = {2014}, doi = {10.1001/jama.2014.93}, pmid = {24549548}, url = {https://doi.org/10.1001/jama.2014.93} } @article{farlow2012-22672770, author = {Farlow, M. and Arnold, S. E. and van Dyck, C. H. and Aisen, P. S. and Snider, B. J. and Porsteinsson, A. P. and Friedrich, S. and Dean, R. A. and others}, title = {{Safety and biomarker effects of solanezumab in patients with Alzheimer's disease}}, journal = {Alzheimer's \& dementia : the journal of the Alzheimer's Association}, year = {2012}, doi = {10.1016/j.jalz.2011.09.224}, pmid = {22672770}, url = {https://doi.org/10.1016/j.jalz.2011.09.224} } @article{cummings2015-26393847, author = {Cummings, J. L. and Lyketsos, C. G. and Peskind, E. R. and Porsteinsson, A. P. and Mintzer, J. E. and Scharre, D. W. and De La Gandara, J. E. and Agronin, M. and others}, title = {{Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia: A Randomized Clinical Trial}}, journal = {JAMA}, year = {2015}, doi = {10.1001/jama.2015.10214}, pmid = {26393847}, url = {https://doi.org/10.1001/jama.2015.10214} } @article{rajji2025-40133524, author = {Rajji, T. K. and Baksh, S. N. and Shade, D. M. and Ismail, Z. and Burhan, A. M. and Okhravi, H. R. and Padala, P. R. and Rosenberg, P. B. and Schneider, L. S. and Porsteinsson, A. P. and others}, title = {{Escitalopram for agitation in Alzheimer's dementia: a randomized controlled phase 3 trial}}, journal = {Nature Medicine}, year = {2025}, doi = {10.1038/s41591-025-03569-y}, pmid = {40133524}, url = {https://doi.org/10.1038/s41591-025-03569-y} } @article{salloway2018-29914022, author = {Salloway, S. P. and Sperling, R. and Fox, N. C. and Sabbagh, M. N. and Honig, L. S. and Porsteinsson, A. P. and Rofael, H. and Ketter, N. and others}, title = {{Long-Term Follow Up of Patients with Mild-to-Moderate Alzheimer's Disease Treated with Bapineuzumab in a Phase III, Open-Label, Extension Study}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2018}, doi = {10.3233/jad-171157}, pmid = {29914022}, url = {https://doi.org/10.3233/jad-171157} } @article{rosenberg2010-20087081, author = {Rosenberg, P. B. and Drye, L. T. and Martin, B. K. and Frangakis, C. and Mintzer, J. E. and Weintraub, D. and Porsteinsson, A. P. and Schneider, L. S. and others}, title = {{Sertraline for the treatment of depression in Alzheimer disease}}, journal = {The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry}, year = {2010}, doi = {10.1097/jgp.0b013e3181c796eb}, pmid = {20087081}, url = {https://doi.org/10.1097/jgp.0b013e3181c796eb} } @article{salloway2011-21917766, author = {Salloway, S. and Sperling, R. and Keren, R. and Porsteinsson, A. P. and van Dyck, C. H. and Tariot, P. N. and Gilman, S. and Arnold, D. and others}, title = {{A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease}}, journal = {Neurology}, year = {2011}, doi = {10.1212/wnl.0b013e3182309fa5}, pmid = {21917766}, url = {https://doi.org/10.1212/wnl.0b013e3182309fa5} }